Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Medtech Reform Trilogues Take Off Amid Turbulence and Late Landing Fears

This article was originally published in SRA

Executive Summary

We have reached the critical phase of the EU negotiations on the proposed Medical Device Regulation and In Vitro Diagnostic Regulation, now the long-awaited trilogue meetings between the European Commission, the Council of the European Union and the European Parliament have begun. Five are planned, but the timings of the final two are not yet written in indelible ink, and the whole program may yet be supplemented or delayed1.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040630

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel